Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in – but the highly anticipated doesn't seem to have lived up to investor expectations. MariTide (maridebart cafraglutide; ...
*Market participants are waiting on key events happening after today's open. *President Trump speaks to the UN at 9:50 a.m. ET, and Fed Chair Powell speaks at 12:35 p.m. about the economic outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback